Home » Stocks » LVTX

LAVA Therapeutics N.V. (LVTX)

Stock Price: $15.36 USD 0.25 (1.65%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
After-hours: $15.10 -0.26 (-1.69%) Apr 9, 4:02 PM
Market Cap 389.41M
Revenue (ttm) 3.89M
Net Income (ttm) -16.57M
Shares Out 25.35M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 9
Last Price $15.36
Previous Close $15.11
Change ($) 0.25
Change (%) 1.65%
Day's Open 15.35
Day's Range 15.00 - 15.87
Day's Volume 16,172
52-Week Range 9.76 - 17.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

UTRECHT, The Netherlands and PHILADELPHIA, April 01, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific gamma-delta T...

1 week ago - GlobeNewsWire

UTRECHT, The Netherlands and PHILADELPHIA, March 24, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics B.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific gamma-delta T...

2 weeks ago - GlobeNewsWire

LAVA Therapeutics, a Dutch Phase 1/2a biotech developing novel bispecific antibodies for cancer, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

1 month ago - NASDAQ

LAVA Therapeutics N.V. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

About LVTX

LAVA Therapeutics is a biotechnology company focused on transforming cancer treatment by developing a platform of novel bispecific antibodies engineered to selectively induce gamma-delta T cell-mediated immunity against tumor cells. Our approach activates Vg9Vd2 T cells, a specific and relatively abundant gamma-delta effector T cell subset, upon cross-linking to a selected tumor target by our bispecific gamma-delta T cell engagers, or gamma-delta bsTCEs. These cells have the natural ability to distinguish tumor cells from healthy cells. Activat... [Read more...]

Industry
Biotechnology
IPO Date
Mar 25, 2021
CEO
Stephen Hurly
Employees
28
Stock Exchange
NASDAQ
Ticker Symbol
LVTX
Full Company Profile

Financial Performance

Financial numbers in millions EUR.
Financial Statements